Evidence map›Paper›PMID 39415682›Full record

ArticleHaematologica2025

Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia.

Florent Puisset, Emmanuel Raffoux, Lionel Ades, Tony Huynh, Raphaël Itzykson, Didier Bouscary, Loréa Aguinana, Florence Rabian, Marie Sebert, Anne Vekhoff and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Florent PuissetAP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; Centre de Recherches en Cancérologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Université de Toulouse, 2 avenue Hubert Curien, CS53717, Toulouse France; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse.
Emmanuel RaffouxAP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944.
Lionel AdesAP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944.
Tony HuynhAP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944.
Raphaël ItzyksonAP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944.
Didier BouscaryAP-HP, Hôpital Cochin, Department of Haematology, Paris.
Loréa AguinanaAP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944.
Florence RabianAP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944.
Marie SebertAP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944.
Anne VekhoffAP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris.
Eolia BrissotAP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris.
Mohamad MohtyAP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris.
Agnes BonninAP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris.
Alexis GenthonAP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris.
Jeremie ZerbitAP-HP, Hôpital Cochin, Department of Haematology, Paris France; AP-HP, Department of Pharmacy, Paris Public Hospital at Home, Paris.
Lise WillemsAP-HP, Hôpital Cochin, Department of Haematology, Paris.
Justine DecrocqAP-HP, Hôpital Cochin, Department of Haematology, Paris.
Adrien ContejeanAP-HP, Hôpital Cochin, Department of Haematology, Paris.
Etienne LenglineAP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944.
Samia MourahAP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris.
Lauriane GoldwirtAP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris. lauriane.goldwirt@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39415682
PMCPMC12208149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.